Phase I/II Randomized, Open-label Trial to Evaluate the PK, Safety, and Outcomes of Treatment Including High Dose Rifampicin +/- Levofloxacin vs Standard Treatment for Pediatric Tuberculous Meningitis (TBM)

Trial Profile

Phase I/II Randomized, Open-label Trial to Evaluate the PK, Safety, and Outcomes of Treatment Including High Dose Rifampicin +/- Levofloxacin vs Standard Treatment for Pediatric Tuberculous Meningitis (TBM)

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 22 Mar 2017

At a glance

  • Drugs Levofloxacin (Primary) ; Rifampicin (Primary) ; Ethambutol; Isoniazid; Pyrazinamide
  • Indications Tubercular meningitis
  • Focus Pharmacokinetics
  • Acronyms TBM-KIDS
  • Most Recent Events

    • 24 Feb 2017 Status changed from not yet recruiting to recruiting.
    • 12 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top